Caricamento...
Solid cancer: the new tumour spread endpoint opens novel opportunities
Novel androgen deprivation agents delay metastasis in non-metastatic, castration-resistant, prostate cancer (nmCRPC). The recent regulatory guidance: considerations for metastasis-free survival endpoint in clinical trials, opens new opportunities in cell biology, medicinal chemistry and advanced ima...
Salvato in:
| Pubblicato in: | Br J Cancer |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6889500/ https://ncbi.nlm.nih.gov/pubmed/31427682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0536-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|